Surfactant protein-A (SP-A) expression in COPD Source: Eur Respir J 2007; 30: Suppl. 51, 138s Year: 2007
Surfactant protein-A serum level is associated with disease control and hospitalisation in patients with bronchial asthma Source: Annual Congress 2010 - Biomarkers and Diagnosis of asthma and allergic respiratory diseases Year: 2010
Protein carbonyls in the lung parenchyma of patients with COPD Source: Annual Congress 2010 - Novel mechanisms in COPD Year: 2010
Morphology of pulmonary tissue in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 456s Year: 2003
Surfactant protein-B polymorphisms, pulmonary function and COPD in 10,231 individuals Source: Annual Congress 2010 - Genetics and risk factors for asthma and COPD Year: 2010
Surfactant protein A (SP-A) and alveolar complement activation in patients at-risk for ARDS Source: Eur Respir J 2002; 20: Suppl. 38, 375s Year: 2002
Surfactant protein D as a potential serum marker of pulmonary emphysema Source: Annual Congress 2011 - Smoking-related disorders and smoking prevention Year: 2011
Lung compliance in patients with pulmonary fibrosis with normal lung volumes Source: Eur Respir J 2007; 30: Suppl. 51, 577s Year: 2007
Association between the human surfactant protein-A (SP-A) gene locus and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 583s Year: 2006
Serum surfactant protein D (SP-D) is a lung derived biomarker for COPD that is responsive to treatment with oral corticosteroids Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008
Lung and serum biomarkers of tissue lesions due to acute exacerbation of COPD Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections Year: 2012
Collagen degradation profile in serum of patients with COPD or IPF Source: Annual Congress 2012 - Monitoring of airway diseases: far from the airways Year: 2012
Characterization of lung volumes in COPD Source: Virtual Congress 2021 – Biomarkers to phenotype COPD: prediction of exacerbations Year: 2021
Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Surfactant pretreatment preserves lung function in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2005; 26: Suppl. 49, 221s Year: 2005
Lung function is improved by surfactant pre-treatment in ischemia-reperfusion-injury of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 204s Year: 2004
Surfactant therapy for RDS and other lung diseases in newborns and adults Source: Eur Respir J 2002; 20: Suppl. 38, 533s Year: 2002
Surfactant protein-D predicts survival in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2009 - Pathogenesis of pulmonary fibrosis Year: 2009
Determinants of protein concentration in whole lung lavage of patients with pulmonary alveolar proteinosis Source: Annual Congress 2009 - From genetics to clinics in diffuse parenchymal lung diseases Year: 2009
Surfactant therapy for acute lung injury and other lung diseases Source: Eur Respir J 2003; 22: Suppl. 45, 210s Year: 2003